Molecular basis of USP7 inhibition by selective small-molecule inhibitors-Reference-Cited by-同舟云学术

Molecular basis of USP7 inhibition by selective small-molecule inhibitors

Published:2017-10 Issue:7677 Volume:550 Page:481-486
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Turnbull Andrew P.,Ioannidis Stephanos,Krajewski Wojciech W.,Pinto-Fernandez Adan,Heride Claire,Martin Agnes C. L.,Tonkin Louise M.,Townsend Elizabeth C.,Buker Shane M.,Lancia David R.,Caravella Justin A.,Toms Angela V.,Charlton Thomas M.,Lahdenranta Johanna,Wilker Erik,Follows Bruce C.,Evans Nicola J.,Stead Lucy,Alli Cristina,Zarayskiy Vladislav V.,Talbot Adam C.,Buckmelter Alexandre J.,Wang Minghua,McKinnon Crystal L.,Saab Fabienne,McGouran Joanna F.,Century Hannah,Gersch Malte,Pittman Marc S.,Marshall C. Gary,Raynham Tony M.,Simcox Mary,Stewart Lorna M. D.,McLoughlin Sheila B.,Escobedo Jaime A.,Bair Kenneth W.,Dinsmore Christopher J.,Hammonds Tim R.,Kim Sunkyu,Urbé Sylvie,Clague Michael J.,Kessler Benedikt M.,Komander David

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature24451.pdf

Reference48 articles.

1. Kruiswijk, F., Labuschagne, C. F. & Vousden, K. H. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat. Rev. Mol. Cell Biol. 16, 393–405 (2015)

2. Wade, M ., Li, Y.-C. & Wahl, G. M. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat. Rev. Cancer 13, 83–96 (2013)

3. Khoo, K. H., Verma, C. S., Lane, D. P. & Lane, D. P. Drugging the p53 pathway: understanding the route to clinical efficacy. Nat. Rev. Drug Discov. 13, 217–236 (2014)

4. Cummins, J. M. et al. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 428, http://dx.doi.org/10.1038/nature02501 (2004)

5. Li, M., Brooks, C. L., Kon, N. & Gu, W. A dynamic role of HAUSP in the p53–Mdm2 pathway. Mol. Cell 13, 879–886 (2004)

Cited by 341 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy;European Journal of Medicinal Chemistry;2024-11

2. Molecular glues that inhibit specific Zn²⁺-dependent DUB activity and inflammation;2024-09-07

3. Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets;Experimental Hematology & Oncology;2024-08-30

4. Hao-Fountain syndrome protein USP7 controls neuronal differentiation via BCOR-ncPRC1.1;2024-08-04

5. Exosomal circ‐0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7/NRF2 axis;Clinical and Translational Medicine;2024-08